PRINCIPLES OF INTRAVESICAL CHEMOTHERAPY AND IMMUNOTHERAPY
- 1 August 1992
- journal article
- review article
- Published by Elsevier in Urologic Clinics of North America
- Vol. 19 (3) , 509-519
- https://doi.org/10.1016/s0094-0143(21)00417-1
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Adjuvant Intravesicular Pharmacotherapy for Superficial Bladder CancerJNCI Journal of the National Cancer Institute, 1991
- Bacillus Calmette-Guérin therapy alters the progression of superficial bladder cancer.Journal of Clinical Oncology, 1988
- Results of 6 Weekly Intravesical Bacillus Calmette-Guerin Instillations on the Treatment of Superficial Bladder TumorsJournal of Urology, 1988
- A prospective randomized trial of maintenance versus nonmaintenance intravesical bacillus Calmette-Guérin therapy of superficial bladder cancer.Journal of Clinical Oncology, 1987
- Risks and Benefits of Repeated Courses of Intravesical Bacillus Calmette-guerin Therapy for Superficial Bladder CancerJournal of Urology, 1987
- Intravesical chemotherapy: In vitro studies on the relationship between dose and cytotoxicityUrological Research, 1986
- The Correlation of TI Bladder Tumour History with Prognosis and Follow-up RequirementsBritish Journal of Urology, 1981
- Single Dose Intravesical Thiotepa as an Adjuvant to Cystodiathermy in the Treatment of Transitional Cell Bladder CarcinomaBritish Journal of Urology, 1976
- BCG and CancerNew England Journal of Medicine, 1974